logo

Juno Therapeutics Inc (JUNO)



Trade JUNO now with
  Date
  Headline
2/21/2018 7:30:55 AM Celgene Receives Antitrust Clearance For Juno Acquisition
2/2/2018 7:30:56 AM Celgene Corp. Commences Tender Offer For Juno Therapeutics
1/22/2018 6:31:03 AM Celgene Agrees To Acquire Juno Therapeutics For $87 Per Share In Cash
1/17/2018 11:23:07 AM Wedbush Lowers Juno Therapeutics Inc (JUNO) To Neutral From Outperform With $70 Up From $64 Price Target
8/29/2017 7:36:53 AM Wedbush Is Lowering Juno Therapeutics Inc (JUNO) 2018 Estimate To -4.06 From -2.77
8/29/2017 7:36:36 AM Wedbush Is Lowering Juno Therapeutics Inc (JUNO) 4Q18 Estimate To -1.09 From -0.76
8/29/2017 7:36:11 AM Wedbush Is Cutting Juno Therapeutics Inc (JUNO) 3Q18 Estimate To -0.99 From -0.55
8/29/2017 7:35:59 AM Wedbush Is Cutting Juno Therapeutics Inc (JUNO) 2Q18 Estimate To -0.97 From -0.74
8/29/2017 7:35:41 AM Wedbush Is Lowering Juno Therapeutics Inc (JUNO) 1Q18 Estimate To -1.00 From -0.72
8/29/2017 7:35:24 AM Wedbush Is Cutting Juno Therapeutics Inc (JUNO) 2017 Estimate To -3.69 From -2.84